Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | TXRH | Common Stock | Options Exercise | $0 | +10K | +89.31% | $0.00 | 21.2K | Jan 10, 2022 | Direct | F1 |
transaction | TXRH | Common Stock | Tax liability | -$293K | -3.25K | -15.35% | $90.22 | 17.9K | Jan 10, 2022 | Direct | |
transaction | TXRH | Common Stock | Sale | -$594K | -6.75K | -37.6% | $88.07 | 11.2K | Jan 11, 2022 | Direct | F2, F3 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | TXRH | Restricted Stock Units | Options Exercise | $0 | -10K | -100% | $0.00* | 0 | Jan 10, 2022 | Common Stock | 10K | Direct | F4, F5 | |
transaction | TXRH | Restricted Stock Units | Award | $0 | +5.5K | $0.00 | 5.5K | Jan 10, 2022 | Common Stock | 5.5K | Direct | F4, F6, F7 |
Id | Content |
---|---|
F1 | Represents restricted stock units that are fully vested on the transaction date. |
F2 | These shares were disposed of pursuant to a written non-discretionary Rule 10b5-1 stock purchase plan dated November 22, 2021. |
F3 | Weighted average sale price reported. The shares were sold within the range of $87.70 to $88.73. The reporting person will provide full information regarding the specific number of shares sold at each separate price upon request by the Commission Staff, the Company, or any security holder of the Company. |
F4 | Each restricted stock unit represents a conditional right to receive one share of the Company's Common Stock. |
F5 | The restricted stock units vested on January 8, 2022. Delivery of the shares to the reporting person occurred on January 10, 2022. |
F6 | Grant of restricted stock units pursuant to the Company's 2021 Long Term Incentive Plan. |
F7 | The restricted stock units vest on January 8, 2023. Delivery of the shares to the reporting person will occur on January 9, 2023, subject to the reporting person's continued service with the Company. |